What I suggested was simply an illustrative example off the top of my head. The fact there's multiple similar companies that already independently exist further

What I suggested was simply an illustrative example off the top of my head. The fact there's multiple similar companies that already independently exist furthers my point. As for your other point, I'd imagine there's a pretty big difference between the capabilities and infrastructure between bringing a drug to market and analyzing the data of people who bring drugs to market.